[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100604086":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":28,"centralContacts":32,"locations":10,"responsibleParty":42,"collaborators":10,"id":44,"slug":45,"hasResults":46,"nctId":47,"briefTitle":48,"officialTitle":49,"acronym":50,"eligibilityCriteria":51,"healthyVolunteers":46,"sex":52,"minAge":53,"maxAge":10,"enrollmentInfo":54,"targetDuration":57,"studyType":58,"phases":10,"briefSummary":59,"conditions":60,"keywords":62,"overallStatus":65,"whyStopped":10,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":10},{"fullName":5,"class":6},"Centre Hospitalier St Anne","OTHER",[8,14,18],{"label":9,"type":10,"description":11,"interventionNames":12},"patients on antiandrogens",null,"standard care",[13],"Radiation: For subjects on SSRIs: bone densitometry",{"label":15,"type":10,"description":16,"interventionNames":17},"patients on SSRI","selective serotonin reuptake inhibitors",[13],{"label":19,"type":10,"description":10,"interventionNames":10},"patient without pharmacological treatment",[21],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"RADIATION","For subjects on SSRIs: bone densitometry","For subjects on SSRIs:\n\nBone densitometry is one of the additional examinations considered. This assessment is part of the routine monitoring for subjects on androgens.",[15,9],[27],"patients on SSRIs",[29],{"name":30,"affiliation":10,"role":31},"Florence THIBAUT, Professor","PRINCIPAL_INVESTIGATOR",[33,38],{"name":30,"role":34,"phone":35,"phoneExt":36,"email":37},"CONTACT","01 58411679","+(33)","florence.thibaut@aphp.fr",{"name":39,"role":34,"phone":40,"phoneExt":36,"email":41},"Ouiza MANSEUR Ouiza, Project manager","01 45 65 84 86","ouiza.manseur@ghu-paris.fr",{"type":43,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100604086","evolution-of-sexual-symptoms-in-paraphilic-sexual-offenders-withwithout-antiandrogen-or-ssri-treatment-100604086",false,"NCT07144943","\"Evolution of Sexual Symptoms in Paraphilic Sexual Offenders With\u002FWithout Antiandrogen or SSRI Treatment\"","Study on the Observation of the Evolution of Sexual Symptoms in Sexual Offenders With Paraphilia (With or Without Antiandrogen or SSRI Treatments)","ESPARA","Inclusion Criteria:\n\n* Men suffering from paraphilias (DSM-5 criteria),\n* Aged 18 to 65 years,\n* Sexual offenders (offense or sexual assault including exhibitionism, rape, sexual touching, incest, possession of pedopornographic video material) (severity level 1 to 6 according to WFSBP recommendations),\n* Subject who has given consent,\n* Patients covered by social security,\n* Satisfactory command of written and spoken French.\"\n\nExclusion Criteria:\n\n* Subject in prison (regardless of the reason),\n* Subject under guardianship (patients under legal supervision may, however, be included),\n* Subjects who have committed a sexual offense and do not meet the DSM-5 criteria for paraphilia.\"","MALE","18 Years",{"count":55,"type":56},200,"ESTIMATED","36 Months","OBSERVATIONAL","The ESPARA study is a multicenter observational research project aiming to monitor, over a three-year period, the evolution of sexual symptoms in male sexual offenders with paraphilia, divided into three groups: receiving antiandrogen treatment, receiving selective serotonin reuptake inhibitors (SSRIs), or no pharmacological treatment. The primary objective is to assess changes in sexual desire intensity and deviant sexual behaviors, while secondary objectives include relapse rates, the role of psychiatric comorbidities, treatment tolerability, and various clinical, cognitive, and life-history factors.",[61],"Sexual Disorder, Physiological",[63,64,50],"sexual offenders","paraphilia","NOT_YET_RECRUITING","2025-08-20",{"date":68,"type":69},"2025-08-28","ACTUAL",{"date":71,"type":56},"2025-09-15",{"date":73,"type":56},"2030-09",{"name":5,"class":6}]